Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.16 USD | +2.03% | +2.74% | -19.45% |
Feb. 26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
Feb. 23 | Sector Update: Health Care Stocks Mixed Premarket Friday | MT |
- Stock
- Equities
- Stock Veracyte, Inc. - Nasdaq
- News Veracyte, Inc.